Suzhou Fengbei Biotech Stock Co., Ltd. (SHA:603334)
China · Delayed Price · Currency is CNY 30.22
+0.38 (1.27%)
Sep 14, 2026, 11:29 AM CST
SHA:603334 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,282 | 5,998 | - | - | - | - | |
Market Cap Growth | - | - | - | - | - | - |
Enterprise Value | 3,851 | 6,264 | - | - | - | - |
Last Close Price | 29.84 | 41.45 | - | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 28.54 | 42.68 | - | - | - | - |
PS Ratio | 1.06 | 1.89 | - | - | - | - |
PB Ratio | 2.47 | 3.53 | - | - | - | - |
P/TBV Ratio | 2.57 | 3.67 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.95 | 1.98 | - | - | - | - |
EV/EBITDA Ratio | 19.23 | 33.77 | - | - | - | - |
EV/EBIT Ratio | 23.75 | 39.78 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.13 | 0.15 | 0.39 | 0.35 | 0.43 | 0.26 |
Debt / EBITDA Ratio | 1.16 | 1.34 | 2.02 | 1.35 | 1.42 | 0.76 |
Debt / FCF Ratio | - | - | - | - | - | 20.05 |
Net Debt / Equity Ratio | -0.25 | -0.36 | 0.17 | 0.10 | 0.00 | 0.04 |
Net Debt / EBITDA Ratio | -2.18 | -3.32 | 0.89 | 0.39 | 0.01 | 0.12 |
Net Debt / FCF Ratio | 2.80 | 12.12 | -2.22 | -10.92 | -0.14 | 3.15 |
Asset Turnover | 2.22 | 1.83 | 1.70 | 1.74 | 2.22 | 2.52 |
Inventory Turnover | 10.37 | 7.62 | 7.82 | 9.84 | 13.27 | 8.91 |
Quick Ratio | 2.42 | 2.34 | 1.20 | 0.99 | 1.10 | 1.21 |
Current Ratio | 3.46 | 3.51 | 2.04 | 1.69 | 1.64 | 1.98 |
Return on Equity (ROE) | 10.63% | 11.45% | 17.88% | 22.70% | 29.78% | 30.80% |
Return on Assets (ROA) | 5.58% | 5.69% | 6.88% | 8.98% | 11.64% | 14.75% |
Return on Invested Capital (ROIC) | 12.25% | 14.66% | 14.75% | 21.29% | 29.15% | 32.70% |
Return on Capital Employed (ROCE) | 9.30% | 9.10% | 14.30% | 20.00% | 25.40% | 31.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.20% | 2.34% | - | - | - | - |
FCF Yield | -3.62% | -0.85% | - | - | - | - |
Dividend Yield | 1.08% | 0.84% | - | - | - | - |
Payout Ratio | 40.15% | 7.36% | 8.59% | 19.56% | 16.50% | 3.80% |
Buyback Yield / Dilution | -21.57% | -5.28% | -0.44% | -1.29% | 0.31% | -6.16% |
Total Shareholder Return | -20.49% | -4.43% | -0.44% | -1.29% | 0.31% | -6.16% |